Thermo Fisher Scientific Inc.

TMONYSE

$667.55

Last price · USD

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

Thermo Fisher Scientific Inc. income statement

Annual · USD millions except per-share data · 26 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Revenue & gross profit
Revenue	44,557	42,879	42,857	44,915	39,211	+3.2%
Cost of revenue	26,318	25,151	25,663	25,904	19,577	+7.7%
Gross profit	18,239	17,728	17,194	19,011	19,634	-1.8%
Operating expenses & income
Research & development	1,397	1,390	1,337	1,471	1,406	-0.2%
SG&A (combined)	8,732	8,676	8,411	9,015	7,910	+2.5%
Total operating expenses	10,129	10,066	9,748	10,486	9,316	+2.1%
Cost and expenses	36,447	35,217	35,411	36,390	28,893	+6.0%
Operating income	8,109	7,662	7,446	8,525	10,318	-5.8%
Non-operating & other
Interest income	993	1,078	879	272	43	+119.2%
Interest expense	1,419	1,654	1,491	726	536	+27.6%
Net interest income	(426)	(576)	(612)	(454)	(493)	—
Non-operating income (excl. interest)	(577)	(1,030)	(343)	(36)	941	—
Other adjustments to net income	34	0	0	0	0	—
Total other income (expenses), net	(842)	(667)	(1,207)	(862)	(1,481)	—
Profitability
Depreciation & amortization	2,780	3,108	3,406	3,381	2,592	+1.8%
Income before tax	7,267	6,995	6,239	7,663	8,837	-4.8%
Income tax expense	547	657	284	703	1,109	-16.2%
Net income from continuing operations	6,720	6,338	5,955	6,960	7,728	-3.4%
Net income	6,737	6,335	5,995	6,950	7,725	-3.4%
Bottom line net income	6,704	6,335	5,995	6,950	7,725	-3.5%
Additional fields
Ebit	8,686	8,692	7,789	8,561	9,377	-1.9%
Ebitda	11,466	11,800	11,195	11,942	11,969	-1.1%
Eps	$17.77	$16.58	$15.53	$17.73	$19.61	-2.4%
Eps Diluted	$17.74	$16.53	$15.45	$17.64	$19.46	-2.3%
Weighted Average Shs Out	376	382	386	392	394	-1.2%
Weighted Average Shs Out Dil	377	383	388	394	397	-1.3%